DBV Technologies S.A. (DBVT)
NASDAQ: DBVT · Real-Time Price · USD
15.65
-0.78 (-4.72%)
At close: Oct 14, 2025, 4:00 PM EDT
15.95
+0.30 (1.92%)
After-hours: Oct 14, 2025, 5:18 PM EDT
DBV Technologies Revenue
DBV Technologies had revenue of $1.47M in the quarter ending June 30, 2025, with 26.18% growth. This brings the company's revenue in the last twelve months to $3.80M, down -72.49% year-over-year. In the year 2024, DBV Technologies had annual revenue of $4.15M, down -73.61%.
Revenue (ttm)
$3.80M
Revenue Growth
-72.49%
P/S Ratio
111.38
Revenue / Employee
$34,545
Employees
110
Market Cap
423.23M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.15M | -11.58M | -73.61% |
Dec 31, 2023 | 15.73M | 10.88M | 224.69% |
Dec 31, 2022 | 4.84M | -864.00K | -15.14% |
Dec 31, 2021 | 5.71M | -5.57M | -49.38% |
Dec 31, 2020 | 11.28M | -3.43M | -23.33% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
DBVT News
- 8 days ago - DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq - GlobeNewsWire
- 26 days ago - DBV Technologies Announces Resignation of Board Member - GlobeNewsWire
- 5 weeks ago - DBV Technologies Establishes an At-The-Market (ATM) Program on Nasdaq - GlobeNewsWire
- 2 months ago - DBV Technologies announces filing of 2025 Half-Year Report ― Conditions for accessing or consulting the Report - GlobeNewsWire
- 2 months ago - DBV Technologies Reports Second Quarter and Half-Year 2025 Financial Results - GlobeNewsWire
- 2 months ago - Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - GlobeNewsWire
- 3 months ago - DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer - GlobeNewsWire
- 3 months ago - DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old - GlobeNewsWire